This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA521962; GEO: GSE126455 |
| Type | Umbrella project |
| Publications | Beaulieu ME et al., "Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.", Sci Transl Med, 2019 Mar 20;11(484) |
| Submission | Registration date: 12-Feb-2019
Peptomyc |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| GEO DataSets | 3 |
GEO Data Details| Parameter | Value |
|---|
| Data volume, Spots | 839851 |
| Data volume, Processed Mbytes | 21 |
| Data volume, Supplementary Mbytes | 73 |
Effect of Omomyc treatment on lung adenocarcinoma of KRasLSL-G12D/+ transgenic mouse and human lung adenocarcinoma cell lines encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Transcriptome or Gene expression | 2 |
BioProject
accession | Organism | Title |
|---|
| PRJNA521969 | Homo sapiens | Effect of Omomyc treatment on human lung adenocarcinoma cell lines (Peptomyc) | | PRJNA521966 | Mus musculus | Effect of Omomyc in vivo treatment on lung adenocarcinoma of KRasLSL-G12D/+ transgenic mouse (Peptomyc) |
|